Electrical Impedance Spectroscopy for Skin Cancer Detection

Reference number
Coordinator SCIBASE AB - SciBase
Funding from Vinnova SEK 3 860 000
Project duration July 2015 - June 2017
Status Completed
Venture The strategic innovation programme Electronic Components and Systems:
Call Strategic Innovation Program. Electronic Components and Systems. R&I Projects spring 2015.

Purpose and goal

Nevisense is the world´s first diagnostic support tool for non-visual detection of malignant melanoma. The goal for the project has been achieved by designing, producing and testing a miniaturized prototype with corresponding performance as Nevisense. Both phantom test and in-vivo test on skin show results comparable with Nevisense but at a much smaller form factor and with far less power consumption.

Expected results and effects

The outcome of the project is a prototype of a miniaturized Nevisense, a pen-like device for measurement of skin impedance. The prototype has been evaluated with electrical phantoms and in-vivo testing on skin. All tests show a performance comparable to the existing Nevisense but in a considerable smaller form factor with less power consumption. This will enable a modular concept that delivers Nevisense capability in an easy-to use form factor with improved integration to the physician workflow.

Planned approach and implementation

The project is conducted in cooperation between SciBase and the ICS-group at KTH. The cooperation has been successful and contributed to many synergy effects. SciBase has contributed with their clinical competence while the ICS-group have contributed with their unique competence within design of miniaturized electronics. The project has followed the time schedule and the test results are above expectation for all involved.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 25 November 2019

Reference number 2015-01369

Page statistics